» Authors » Juan A del Olmo

Juan A del Olmo

Explore the profile of Juan A del Olmo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 469
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Felipo V, Urios A, Garcia-Torres M, El Mlili N, del Olmo J, Civera M, et al.
Obesity (Silver Spring) . 2013 Feb; 21(2):229-37. PMID: 23404955
Objective: Obesity-associated nonalcoholic fatty liver disease (NAFLD), covering from simple steatosis to nonalcoholic steatohepatitis (NASH), is a common cause of chronic liver disease. Aberrant production of adipocytokines seems to play...
2.
Felipo V, Urios A, Montesinos E, Molina I, Garcia-Torres M, Civera M, et al.
Metab Brain Dis . 2011 Nov; 27(1):51-8. PMID: 22072427
To assess the contribution of hyperammonemia and inflammation to induction of mild cognitive impairment (or MHE). We analyzed the presence of mild cognitive impairment (CI) by using the PHES battery...
3.
Montoliu C, Cauli O, Urios A, ElMlili N, Serra M, Giner-Duran R, et al.
Am J Gastroenterol . 2011 Apr; 106(9):1629-37. PMID: 21483460
Objectives: Between 30 and 50% of the cirrhotic patients who do not show symptoms of clinical hepatic encephalopathy (HE) present minimal hepatic encephalopathy (MHE), with mild cognitive impairment. MHE impairs...
4.
Lluch P, Cortina B, Vila J, Segarra G, Mauricio M, del Olmo J, et al.
Scand J Gastroenterol . 2008 Oct; 44(2):224-8. PMID: 18951278
Objective: Previous studies have shown that asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and nitric oxide (NO) play a prominent role in liver dysfunction. The objective of this study was to...
5.
Montoliu C, Piedrafita B, Serra M, del Olmo J, Urios A, Rodrigo J, et al.
J Clin Gastroenterol . 2008 Jun; 43(3):272-9. PMID: 18562979
Background And Aims: Patients with liver cirrhosis may present minimal hepatic encephalopathy (MHE) that can be unveiled using specific neuropsychologic examination. Evaluation of MHE in cirrhotic patients might have prognostic...
6.
Escudero A, Rodriguez F, Serra M, del Olmo J, Montes F, Rodrigo J
J Gastroenterol Hepatol . 2008 Apr; 23(6):861-6. PMID: 18422960
Background And Aim: We assessed whether the two regimens of pegylated alpha-interferon-2b (PEG-IFN-alpha2b) plus ribavirin and pegylated alpha-interferon-2a (PEG-IFN-alpha2a) plus ribavirin showed differences in terms of sustained virological response, withdrawal...
7.
Romero-Gomez M, Cordoba J, Jover R, del Olmo J, Ramirez M, Rey R, et al.
Hepatology . 2007 Mar; 45(4):879-85. PMID: 17393525
Unlabelled: Minimal hepatic encephalopathy (MHE) is mainly diagnosed using psychometric tests such as the psychometric hepatic encephalopathy score (PHES). Despite the clinical and social relevance of MHE, psychometric testing is...
8.
Montoliu C, Piedrafita B, Serra M, del Olmo J, Ferrandez A, Rodrigo J, et al.
J Mol Med (Berl) . 2007 Jan; 85(3):237-45. PMID: 17216205
Patients with liver cirrhosis with normal neurological and mental status examination may present minimal forms of hepatic encephalopathy, showing intellectual function impairment that cannot be detected through general clinical examination...
9.
Montoliu C, Piedrafita B, Serra M, del Olmo J, Rodrigo J, Felipo V
Am J Physiol Gastrointest Liver Physiol . 2007 Jan; 292(1):G305-14. PMID: 17215436
Hepatic encephalopathy in patients with liver disease is associated with poor prognosis. This could be due to the induction by the transient episode of hepatic encephalopathy of long-lasting alterations making...
10.
del Olmo J, Ornia E, Serra M, Garcia-Torres M, Escudero A, Rodriguez F, et al.
J Gastroenterol Hepatol . 2006 May; 21(6):982-7. PMID: 16724982
Background: Diagnostic and preventive measures have contributed to a change in the epidemiology of acute hepatitis. The purpose of the present paper was to assess the changing prevalence of acute...